Cadrenal Therapeutics, Inc.

About Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing transformative therapeutics to address gaps in anticoagulation therapy. Their mission is to improve the quality of life and patient outcomes for individuals with rare cardiovascular conditions by bringing novel therapies to market.

Products & Services

Tecarfarin:A Phase 3-ready anticoagulant drug designed to be a superior and safer vitamin K antagonist (VKA) compared to warfarin. It aims to provide stable and effective anticoagulation for patients with implanted cardiac devices and rare cardiovascular conditions, with reduced adverse events.

Factor XIa Inhibitors:A portfolio of novel assets acquired from eXIthera, enhancing the company's pipeline for acute and chronic anticoagulation settings.

Specialties

Anticoagulation Therapy Cardiovascular Conditions Implanted Cardiac Devices (LVADs, MHVs) End-Stage Kidney Disease (ESKD) with Atrial Fibrillation (AFib)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Warrant Exercise T: - FT: Warrant Exercise	A: 4700000 MR: - FA: $4.7 million FAN: 4700000	D: 2024-11-01 FD: 2024-11-01	-
2	RT: ATM Facility T: - FT: ATM Facility	A: 5100000 MR: - FA: 5.1 million FAN: 5100000	D: 2024-10-24 FD: 2024-10-24	-
3	RT: Private Placement T: - FT: Private Placement	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2023-07-14 FD: 2023-07-14	1 investors
4	RT: Private Placement T: - FT: Private Placement	A: 7500000 MR: - FA: 7.5 million FAN: 7500000	D: 2023-07-12 FD: 2023-07-12	1 investors
5	RT: IPO T: - FT: IPO	A: 7000000 MR: - FA: $7,000,000 FAN: 7000000	D: 2023-01-24 FD: 2023-01-24	1 investors

Warrant Exercise Latest

2024-11-01

$4.7M

ATM Facility 2024-10-24

$5.1M

Private Placement 2023-07-14

$7.5M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Q

Quang Pham

Chairman & Chief Executive Officer

M

Matthew Szot

Chief Financial Officer and Co-Founder

J

Jeff Cole

Chief Operating Officer

J

James Ferguson

Chief Medical Officer

J

John R. Murphy

Board Member

S

Steven Zelenkofske

Board Member

View 11 more team members with Pro

Unlock Full Team Directory

Recent News